The KPN 2019 analyst day: the company is changing its strategy after M&A fails to deliver revenue growth
KPN is one within a group of operators aggressively targeting growth through acquisition. This strategy appears to have changed, with more importance being placed on cost-cutting and rationalisation in 2019. This article explores the implications of this strategy for KPN and for others.
KPNs strategy has shifted from a focus on creating new opportunties to a more-modest aim of stabilising service revenue between 2019 and 2021.
Netherlands Cancer Diagnostics Marketual Tumor Markers
This unique report from provides information and analysis not available from any other published source, including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor
View Report2021 Robert Half International Strategic SWOT Analysis--Performance, Capabilities, Goals and Strategies in the Global Business Services Industry
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the
View ReportThe KPN analyst day: its focus is on healthcare, government and manufacturing verticals in the Netherlands
With enterprise revenue falling by more than 7% between 2015–2016, KPN has a challenge to return this division to growth. At its analyst day in April 2017, KPN outlined its
View ReportFill The Form For Sample Request
